Cognitive Dysfunction in Patients With Major Depressive Disorder, Clinical Peculiarities, Biological Markers, and Treatment Efficacy
Phase of Trial: Phase IV
Latest Information Update: 17 Jan 2019
At a glance
- Drugs Escitalopram (Primary) ; Vortioxetine (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- 08 Jan 2019 Planned End Date changed from 1 Sep 2018 to 1 Apr 2019.
- 08 Jan 2019 Planned primary completion date changed from 1 Jul 2018 to 1 Apr 2019.
- 31 Aug 2018 Biomarkers information updated